...
【24h】

Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals.

机译:氨基胍在实验动物糖尿病性视网膜病和肾病中的潜在预防作用。

获取原文
获取原文并翻译 | 示例
           

摘要

This study sought to determine the potential prophylactic and antioxidant effects of aminoguanidine in experimentally induced diabetes. Four groups of Wistar rats, each composed of ten rats, were used. Two groups served as control. In group 3, diabetes was induced by a single intraperitoneal injection of streptozotocin (65 mg kg-1). In group 4, diabetes was induced and treated with aminoguanidine (100 mg kg-1 daily) orally for 3 months. Levels of serum glucose, glutathione peroxidase, glutathione reductase and erythrocytes catalase were analyzed on day 90 of the experiment. Retinal and kidney specimens were examined histopathologically after sacrifice of the animals. A significant antioxidant effect of aminoguanidine and its prophylactic role in diabetic retinopathy and nephropathy were observed in experimental animals.
机译:这项研究试图确定氨基胍在实验诱导的糖尿病中的潜在预防和抗氧化作用。使用四组Wistar大鼠,每组由十只大鼠组成。两组作为对照。在第3组中,腹膜内注射链脲佐菌素(65 mg kg-1)可诱发糖尿病。在第4组中,糖尿病患者被诱导并口服氨基胍(每天100 mg kg-1)治疗3个月。在实验的第90天分析血清葡萄糖,谷胱甘肽过氧化物酶,谷胱甘肽还原酶和红细胞过氧化氢酶的水平。处死动物后,对视网膜和肾脏标本进行组织病理学检查。在实验动物中观察到了氨基胍的显着抗氧化作用及其在糖尿病性视网膜病和肾病中的预防作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号